Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001171843-24-005324
Filing Date
2024-09-24
Accepted
2024-09-24 06:06:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 f424b3_092324.htm 424B3 21699
2 GRAPHIC logo.jpg GRAPHIC 15073
  Complete submission text file 0001171843-24-005324.txt   43609
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267328 | Film No.: 241317460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)